{"name":"The Column Group","permalink":"the-column-group","crunchbase_url":"http://www.crunchbase.com/financial-organization/the-column-group","homepage_url":"http://www.thecolumngroup.net","blog_url":"","blog_feed_url":"","twitter_username":"","phone_number":"415.865.2050","description":"Venture capital Firm","email_address":"info@thecolumngroup.net","number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"tag_list":null,"alias_list":"","created_at":"Wed Jun 17 21:23:01 UTC 2009","updated_at":"Fri Jun 19 02:41:04 UTC 2009","overview":"<p>The Column Group is a leading venture capital firm dedicated to creating the next generation of biotechnology companies</p>","image":{"available_sizes":[[[150,105],"assets/images/resized/0004/9539/49539v1-max-150x150.png"],[[230,162],"assets/images/resized/0004/9539/49539v1-max-250x250.png"],[[230,162],"assets/images/resized/0004/9539/49539v1-max-450x450.png"]],"attribution":null},"offices":[{"description":"","address1":"1700 Owens Street","address2":"Suite 595","zip_code":"94158","city":"San Francisco","state_code":"CA","country_code":"USA","latitude":37.7679113,"longitude":-122.3941495}],"relationships":[{"is_past":false,"title":"Managing Partner","person":{"first_name":"Harald","last_name":"Ekman","permalink":"harald-ekman","image":{"available_sizes":[[[105,150],"assets/images/resized/0004/9541/49541v1-max-150x150.jpg"],[[120,170],"assets/images/resized/0004/9541/49541v1-max-250x250.jpg"],[[120,170],"assets/images/resized/0004/9541/49541v1-max-450x450.jpg"]],"attribution":""}}}],"investments":[{"funding_round":{"round_code":"a","source_url":"http://onbiovc.com/aragon-pharmaceuticals-inc-series-a-8m/","source_description":"Aragon Pharmaceuticals, Inc.: Series A $8M","raised_amount":8000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":5,"funded_day":27,"company":{"name":"Aragon Pharmaceuticals","permalink":"aragon-pharmaceuticals","image":{"available_sizes":[[[150,43],"assets/images/resized/0004/9225/49225v2-max-150x150.jpg"],[[226,66],"assets/images/resized/0004/9225/49225v2-max-250x250.jpg"],[[226,66],"assets/images/resized/0004/9225/49225v2-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"","source_description":"Capital Funding Report","raised_amount":24550000,"raised_currency_code":"USD","funded_year":2008,"funded_month":2,"funded_day":1,"company":{"name":"NGM Biopharmaceuticals","permalink":"ngm-biopharmaceuticals","image":{"available_sizes":[[[150,60],"assets/images/resized/0004/9534/49534v1-max-150x150.jpg"],[[185,75],"assets/images/resized/0004/9534/49534v1-max-250x250.jpg"],[[185,75],"assets/images/resized/0004/9534/49534v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://deals.venturebeat.com/2008/06/20/vaccsys-raises-9-million-for-vaccine-research/","source_description":"Vaccsys raises $9 million for vaccine research","raised_amount":9000000,"raised_currency_code":"USD","funded_year":2008,"funded_month":6,"funded_day":20,"company":{"name":"Vaccsys","permalink":"vaccsys","image":{"available_sizes":[[[150,22],"assets/images/resized/0005/9445/59445v1-max-150x150.png"],[[250,37],"assets/images/resized/0005/9445/59445v1-max-250x250.png"],[[450,67],"assets/images/resized/0005/9445/59445v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.3vbio.com/3VBiosciencesNewsRelease071009.pdf","source_description":"3-V Biosciences, Inc. Secures $30 Million in Series B Funding, Welcomes New Members to Board of Directors","raised_amount":30000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":7,"funded_day":10,"company":{"name":"3-V Biosciences","permalink":"3-v-biosciences","image":{"available_sizes":[[[150,82],"assets/images/resized/0006/1988/61988v1-max-150x150.png"],[[212,117],"assets/images/resized/0006/1988/61988v1-max-250x250.png"],[[212,117],"assets/images/resized/0006/1988/61988v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.constellationpharma.com/pr_081309.htm","source_description":"Constellation Pharmaceuticals, Inc.  Closes $17 Million in Funding ","raised_amount":17200000,"raised_currency_code":"USD","funded_year":2009,"funded_month":8,"funded_day":13,"company":{"name":"Constellation Pharmaceuticals","permalink":"constellation-pharmaceuticals","image":{"available_sizes":[[[150,62],"assets/images/resized/0006/2182/62182v1-max-150x150.jpg"],[[231,96],"assets/images/resized/0006/2182/62182v1-max-250x250.jpg"],[[231,96],"assets/images/resized/0006/2182/62182v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"e","source_url":"http://www.finsmes.com/2009/12/ptc-therapeutics-raises-50m-in-equity.html","source_description":"PTC Therapeutics Raises 50M in Equity Financing","raised_amount":50000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":12,"funded_day":22,"company":{"name":"PTC Therapeutics","permalink":"ptc-therapeutics","image":{"available_sizes":[[[150,69],"assets/images/resized/0006/8365/68365v1-max-150x150.jpg"],[[208,97],"assets/images/resized/0006/8365/68365v1-max-250x250.jpg"],[[208,97],"assets/images/resized/0006/8365/68365v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.fiercebiotech.com/story/aragon-pharma-readies-first-cancer-trial-after-22m-b-round/2010-04-22","source_description":"Aragon Pharma readies first cancer trial after $22M B round ","raised_amount":22000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":4,"funded_day":22,"company":{"name":"Aragon Pharmaceuticals","permalink":"aragon-pharmaceuticals","image":{"available_sizes":[[[150,43],"assets/images/resized/0004/9225/49225v2-max-150x150.jpg"],[[226,66],"assets/images/resized/0004/9225/49225v2-max-250x250.jpg"],[[226,66],"assets/images/resized/0004/9225/49225v2-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://onbiovc.com/constellation-pharmaceuticals-inc-series-b-48m/","source_description":"Constellation Pharmaceuticals, Inc.: Series B $4.8M","raised_amount":4800000,"raised_currency_code":"USD","funded_year":2010,"funded_month":6,"funded_day":7,"company":{"name":"Constellation Pharmaceuticals","permalink":"constellation-pharmaceuticals","image":{"available_sizes":[[[150,62],"assets/images/resized/0006/2182/62182v1-max-150x150.jpg"],[[231,96],"assets/images/resized/0006/2182/62182v1-max-250x250.jpg"],[[231,96],"assets/images/resized/0006/2182/62182v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://onbiovc.com/igenica-inc-series-b-24m/","source_description":"Igenica, Inc.: Series B $24M","raised_amount":24000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":6,"funded_day":14,"company":{"name":"Igenica","permalink":"igenica","image":{"available_sizes":[[[150,65],"assets/images/resized/0009/0611/90611v1-max-150x150.jpg"],[[250,109],"assets/images/resized/0009/0611/90611v1-max-250x250.jpg"],[[265,116],"assets/images/resized/0009/0611/90611v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.xconomy.com/seattle/2010/07/26/immune-design-nabs-32m-for-targeted-vaccines/","source_description":"Immune Design Nabs $32M for Targeted Vaccines","raised_amount":32000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":7,"funded_day":26,"company":{"name":"Immune Design","permalink":"immune-design","image":{"available_sizes":[[[150,40],"assets/images/resized/0009/5060/95060v1-max-150x150.png"],[[220,60],"assets/images/resized/0009/5060/95060v1-max-250x250.png"],[[220,60],"assets/images/resized/0009/5060/95060v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.xconomy.com/boston/2008/07/07/immune-design-aiming-to-make-vaccines-that-work-better-in-a-single-shot/","source_description":"Immune Design Aiming To Make Vaccines That Work Better in a Single Shot","raised_amount":18000000,"raised_currency_code":"USD","funded_year":2008,"funded_month":7,"funded_day":7,"company":{"name":"Immune Design","permalink":"immune-design","image":{"available_sizes":[[[150,40],"assets/images/resized/0009/5060/95060v1-max-150x150.png"],[[220,60],"assets/images/resized/0009/5060/95060v1-max-250x250.png"],[[220,60],"assets/images/resized/0009/5060/95060v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.finsmes.com/2011/06/constellation-pharmaceuticals-raises-15m-series-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Constellation Pharmaceuticals Raises $15M in Series B Financing","raised_amount":15000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":6,"funded_day":6,"company":{"name":"Constellation Pharmaceuticals","permalink":"constellation-pharmaceuticals","image":{"available_sizes":[[[150,62],"assets/images/resized/0006/2182/62182v1-max-150x150.jpg"],[[231,96],"assets/images/resized/0006/2182/62182v1-max-250x250.jpg"],[[231,96],"assets/images/resized/0006/2182/62182v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.finsmes.com/2011/06/cyterix-pharmaceutics-raises-9-2m-series-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Cyterix Pharmaceutics Raises $9.2M in Series A Financing","raised_amount":9200000,"raised_currency_code":"USD","funded_year":2011,"funded_month":6,"funded_day":7,"company":{"name":"Cyterix Pharmaceuticals","permalink":"cyterix-pharmaceuticals","image":{"available_sizes":[[[150,41],"assets/images/resized/0013/8156/138156v1-max-150x150.png"],[[250,69],"assets/images/resized/0013/8156/138156v1-max-250x250.png"],[[280,78],"assets/images/resized/0013/8156/138156v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.finsmes.com/2011/07/peloton-therapeutics-completes-18m-series-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Peloton Therapeutics Completes $18M Series A Financing","raised_amount":18000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":7,"funded_day":27,"company":{"name":"Peloton Therapeutics","permalink":"peloton-therapeutics","image":{"available_sizes":[[[150,70],"assets/images/resized/0014/6607/146607v1-max-150x150.png"],[[216,101],"assets/images/resized/0014/6607/146607v1-max-250x250.png"],[[216,101],"assets/images/resized/0014/6607/146607v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.finsmes.com/2012/06/igenica-raises-33m-series-funding.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Igenica Raises $33M in Series C Funding","raised_amount":33000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":6,"funded_day":12,"company":{"name":"Igenica","permalink":"igenica","image":{"available_sizes":[[[150,65],"assets/images/resized/0009/0611/90611v1-max-150x150.jpg"],[[250,109],"assets/images/resized/0009/0611/90611v1-max-250x250.jpg"],[[265,116],"assets/images/resized/0009/0611/90611v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://www.prnewswire.com/news-releases/aragon-pharmaceuticals-raises-50-million-in-series-d-financing-to-advance-promising-therapeutic-candidates-for-hormone-driven-cancers-172635221.html","source_description":"Aragon Pharmaceuticals Raises $50 Million in Series D Financing to Advance Promising Therapeutic Candidates for Hormone-Driven Cancers","raised_amount":50000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":10,"funded_day":4,"company":{"name":"Aragon Pharmaceuticals","permalink":"aragon-pharmaceuticals","image":{"available_sizes":[[[150,43],"assets/images/resized/0004/9225/49225v2-max-150x150.jpg"],[[226,66],"assets/images/resized/0004/9225/49225v2-max-250x250.jpg"],[[226,66],"assets/images/resized/0004/9225/49225v2-max-450x450.jpg"]],"attribution":null}}}}],"milestones":[],"providerships":[],"funds":[{"name":"Column Group II","funded_year":2010,"funded_month":3,"funded_day":10,"raised_amount":65500000,"raised_currency_code":"USD","source_url":"http://www.sec.gov/Archives/edgar/data/1478715/000147871510000001/xslFormDX01/primary_doc.xml","source_description":"SEC D"}],"video_embeds":[],"external_links":[]}